Innovative microfluidic chip uses only standard lab microscope to spot nano-biomolecules without any fluorescent labels
A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment.
Diseases diagnostics involves detection and quantification of nano-sized bio-particles such as DNA, proteins, viruses, and exosomes (extracellular vesicles). Typically, detection of biomolecules such as proteins are performed using colorimetric assays or fluorescent labelling with a secondary antibody for detection, and requires complex optical detection equipment such as fluorescent microscopy or spectrophotometry.
One alternative to reduce cost and complexity of disease detection is the adoption of label-free techniques, which are gaining traction in recent times. However, this approach requires precision engineering of nano-features (in a detection chip), complex optical setups, novel nano-probes (such as graphene oxide, carbon nanotubes, and gold nanorods) or additional amplification steps such as aggregation of nanoparticles to achieve sensitive detection of biomarkers.
“Our invention is an example of disruptive diagnostics. This tiny biochip can sensitively detect proteins and nano-sized polymer vesicles with a concentration as low as 10ng/mL (150 pM) and 3.75?g/mL respectively. It also has a very small footprint, weighing only 500 mg and is 6mm³ in size. Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics,” explained Prof Zhang.
His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in scientific journal Nature Communications on 28 March 2018.
Novel approach for disease diagnosis
This novel fluorescent label-free approach uses the lateral shifts in the position of the microbead substrate in pillar arrays, for quantifying the biomolecules, based on the change in surface forces and size, without the need of any external equipment. Due to the usage of lateral displacement, the nano-biomolecules can be detected in real-time and the detection is significantly faster in comparison to fluorescent label based detection.
“These techniques can also be extended to many other types of nano-biomolecules, including nucleic acid and virus detection. To complement this chip technology, we are also developing a portable smartphone-based accessory and microfluidic pump to make the whole detection platform portable for outside laboratory disease diagnostics. We hope to further develop this technology for commercialisation,” said Prof Zhang.
The Latest on: Disease detection
via Google News
The Latest on: Disease detection
- Researchers testing early detection, prevention for deadly canine canceron October 19, 2019 at 6:23 am
Researchers use a blood test to look for the cells responsible for establishing the disease then follow up with an experimental treatment that attacks those cells and prevents a tumor from developing.
- New Lyme Disease Testing Aims to Streamline Diagnosison October 18, 2019 at 12:13 pm
Full Critique A new testing paradigm for Lyme disease could improve early detection by nearly one-third, while drastically reducing test turnaround time. The manufacturer of the tests is currently ...
- Hereditary Cancer Testing Markets, 2019-2027 - Growing Demand for Non-invasive Methods of Detection Presents Opportunitieson October 17, 2019 at 5:27 pm
Genomic analysis is used to monitor, diagnose, treat, forecast, and prevent diseases, and promote good health in persons. The technological advances have allowed more significant integration of ...
- Sarawak duo develop AI for early heart disease detectionon October 17, 2019 at 4:00 pm
KUCHING: Two Sarawakian researchers have developed a technology using artificial intelligence (AI) to provide early detection of heart disease. Specifically, the work of Prof Patrick Then and Dr Brian ...
- WHO report finds that TB continuous to be the leading infectious disease killeron October 17, 2019 at 12:38 pm
The WHO report finds that TB remains the leading global infectious disease killer. WHO's data shows that while TB deaths declined slightly ... On drug resistant TB (DR), WHO reports a slight ...
- Scientists develop test for uncommon brain diseaseson October 16, 2019 at 9:50 am
Alzheimer's disease and chronic traumatic encephalopathy (CTE). They adapted the test to use CSF for the detection of abnormal tau of progressive supranuclear palsy (PSP), corticobasal degeneration ...
- Protein misfolding as a risk marker for Alzheimer's diseaseon October 16, 2019 at 6:06 am
In symptom-free individuals, the detection of misfolded amyloid-beta protein in the blood indicated a considerably higher risk of Alzheimer's disease -- up to 14 years before a clinical diagnosis was ...
- Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysison October 15, 2019 at 3:12 pm
Studies with cytological endpoint assessment only were excluded because of the lower sensitivity for cytology measures in detection of high-grade disease. 12 Medline, Embase and Cochrane databases ...
- Adjusting memory test may better detect Alzheimer's disease in women, study sayson October 15, 2019 at 2:28 pm
More than two-thirds of the 5 million Americans living with Alzheimer's disease are women. But early detection of the disease is more likely in men than women. Adjusting memory tests used to detect ...
via Bing News